Concepedia

Alexander Y. Deneka

AY

15

Publications

505

Citations

12

H-Index

2015

Active since

Affiliations

Fox Chase Cancer Center(Current)

Kazan Federal University

Drexel University

Temple University

Jiangsu University

Alexander Y. Deneka is an author at Fox Chase Cancer Center specializing in pharmacology, tumor microenvironment, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2015–2023

15

Publications

15

Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis

Alexander E. Kudinov, Alexander Y. Deneka, Anna S. Nikonova et al. · Proceedings of the National Academy of Sciences · 2016 · 143 citations · Full text

Association of <i>T</i> <i>P53</i> and <i>CDKN2A</i> Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer

Alexander Y. Deneka, Yasmine Baca, Ilya G. Serebriiskii et al. · Clinical Cancer Research · 2022 · 85 citations · Full text

Ganetespib limits ciliation and cystogenesis in autosomal‐dominant polycystic kidney disease (ADPKD)

Anna S. Nikonova, Alexander Y. Deneka, Anna A. Kiseleva et al. · The FASEB Journal · 2018 · 36 citations · Full text

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

Petr Makhov, Igor Bychkov, Bulat Faezov et al. · Oncogenesis · 2021 · 36 citations · Full text

A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer

Anna V. Gaponova, Anna S. Nikonova, Alexander Y. Deneka et al. · Clinical Cancer Research · 2016 · 32 citations

Rows per page

1–5 of 15